Harvard T.H. Chan School of Public Health, Boston, Massachusetts (Rebbeck); Dana-Farber Cancer Institute, Boston, Massachusetts (Rebbeck, Mack, George, Wagle); The Ohio State University, Columbus, Ohio (Bridges, Crossnohere, Paskett); City of Hope, Duarte, California (Gray); The Translational Genomics Research Institute, Phoenix, Arizona (Trent); Broad Institute to Broad Institute of MIT and Harvard and Count Me In, Cambridge, Massachusetts (Painter, Wagle); University of New Mexico Comprehensive Cancer Center and Health Sciences Center, Albuquerque (Kano, Mishra, Willman, Sussman); Black Hills Center for American Indian Health, Rapid City, South Dakota (Nez Henderson, Henderson); Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, Minnesota (Willman).
JAMA Health Forum. 2022 Apr;3(4). doi: 10.1001/jamahealthforum.2022.0603. Epub 2022 Apr 15.
Research into the genetic and genomic ("genomics") foundations of disease is central to our understanding of disease prevention, early detection, diagnostic accuracy, and therapeutic intervention. Inequitable participation in genomics research by historically excluded populations limits the ability to translate genomic knowledge to achieve health equity and ensure that findings are generalizable to diverse populations.
We propose a novel framework for promoting diversity, equity, and inclusion in genomics research. Building on principles of community-based participatory research and collective impact frameworks, the framework can guide our understanding of the social, cultural, health system, policy, community, and individual contexts in which engagement and genomics research are being done. Our framework highlights the involvement of a multistakeholder team, including the participants and communities to be engaged, to ensure robust methods for recruitment, retention, return of genomic results, quality of engagement, follow-up, and monitoring of participants.
The proposed engagement framework will guide investigators in optimizing equitable representation in research and enhancing the rigor of genomics investigation.
对疾病的遗传和基因组(“基因组学”)基础的研究是我们理解疾病预防、早期发现、诊断准确性和治疗干预的核心。历史上被排除在外的人群在基因组学研究中的不平等参与限制了将基因组知识转化为实现健康公平并确保研究结果可推广到不同人群的能力。
我们提出了一个促进基因组学研究中的多样性、公平性和包容性的新框架。该框架基于社区参与式研究和集体影响框架的原则,可以指导我们理解参与和基因组学研究所处的社会、文化、卫生系统、政策、社区和个人背景。我们的框架强调了多利益攸关方团队的参与,包括要参与的参与者和社区,以确保有稳健的方法来招募、留住、回报基因组结果、参与质量、随访和监测参与者。
拟议的参与框架将指导研究人员优化研究中的公平代表性,并提高基因组学研究的严谨性。